Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer of the prostate

M B Maxwell1

  • 1Nursing Service, Veterans Affairs Medical Center, Portland, OR 97207.

Seminars in Oncology Nursing
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Early prostate cancer detection and treatment decisions remain complex. Advances improve diagnosis and surgery, but optimal screening, tumor marker use, and prognostic tools require further research for effective prostate cancer management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy-induced myelosuppression.

Seminars in oncology nursing·1992
Same author

Confessions of a cancer nurse.

Seminars in oncology nursing·1987
Same author

Dyspnea in advanced cancer.

The American journal of nursing·1985
Same author

When the cancer patient becomes anemic.

Cancer nursing·1984
Same author

Pedal edema in the cancer patient.

The American journal of nursing·1982
Same author

The use of social networks to help cancer patients maximize support.

Cancer nursing·1982
Same journal

Boundary Erosion in Oncology Nursing: Psychosocial Consequences and Coping Strategies-A Qualitative Study.

Seminars in oncology nursing·2026
Same journal

Health-Related Quality of Life in Cancer Cachexia: Validation of the Turkish Version of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT).

Seminars in oncology nursing·2026
Same journal

A Dyadic Study of Lived Experiences of Family Stress, Emotional Distress and Family Resilience Among Women With Cancer During Pregnancy and Their Partners.

Seminars in oncology nursing·2026
Same journal

Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.

Seminars in oncology nursing·2026
Same journal

Refining Genomic Integration in Hereditary Breast Cancer: Reflections on Clinical and Nursing Implications.

Seminars in oncology nursing·2026
Same journal

Bridge Symptoms Between Symptom Clusters in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy: A Network Analysis.

Seminars in oncology nursing·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer is a leading cause of cancer death in men.
  • Recent advancements in screening and imaging facilitate earlier diagnosis.
  • Surgical improvements have lessened post-prostatectomy complications like incontinence and sexual dysfunction.

Purpose of the Study:

  • To address outstanding questions in prostate cancer detection and management.
  • To explore the optimal use of tumor markers for diagnosis and prognosis.
  • To evaluate screening strategies and prognostic tools for personalized therapy decisions.

Main Methods:

  • Review of current screening and diagnostic modalities.
  • Analysis of the role of prostate-specific antigen (PSA) and other tumor markers.
  • Evaluation of prognostic factors and treatment decision-making tools.

Related Experiment Videos

Main Results:

  • Early detection remains a challenge despite improved diagnostic technologies.
  • The precise role and optimal application of tumor markers require further clarification.
  • Evidence-based guidelines for screening and risk stratification are still evolving.

Conclusions:

  • Further research is needed to refine prostate cancer screening protocols.
  • Development of better prognostic tools is essential for guiding therapy selection.
  • Optimizing the use of tumor markers can improve patient outcomes and treatment efficacy.